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In the last two decades desmosomal research has developed
from a highly specialized area of cell biology to an area of
biomedicalresearchaimedatelucidatingtheroleofthesecell
junctions in tissue and organ development and homeostasis.
Until the late 1980s, desmosomal research focused, to
a large extent, on the morphological characterization of
desmosomes and the biochemical identiﬁcation of desmoso-
malproteins.Towardstheendofthatdecade,theﬁrstdesmo-
somal transmembrane proteins (desmogleins and desmo-
collins) were cloned, demonstrating that these proteins are
sequencerelatedtocadherins,afamilyofcalcium-dependent
cell adhesion proteins. Subsequent knockout experiments
in mice, published in the 1990s, demonstrated that at least
some of the desmosomal cadherins (e.g., desmoglein 3) are
required to maintain tissue integrity in the oral mucosa (see
the paper of Ganeshan et al.). Around the same time, it was
shown that patients who suﬀer from autoimmune diseases
characterized by skin and mucous membrane blistering
produce autoantibodies against desmogleins 1 and 3 (DSG1,
DSG3). These two observations suggested that the loss of
normal desmosome function could lead to tissue fragility
disorders.
Subsequent to the identiﬁcation of pemphigus as a
desmosomaldisease,reportsbegantoemergesuggestingthat
mutations in desmosomal genes can cause a variety of skin
blistering disorders and cardiomyopathy (see the paper by J.
L ia n dG .L .R a d i c e ) .
Recently the question has emerged: Are all desmosomal
diseases causedbyaloss ofcelladhesion? Mounting evidence
suggests that abnormal cell signaling might contribute to
the pathophysiology of at least certain types of desmosomal
diseases, such as pemphigus (see the paper of M. Bektas et al.
and D. Brennan et al.). The putative contributions of cell
adhesion defects and abnormal cell signaling in diseases like
pemphigus are still under intense debate. We can expect to
see a continued inﬂux of exciting new ﬁndings in this area.
The present special issue is a collection of reviews and
original research articles that focus on fundamental aspects
of desmosome biology and on clinical research relating to
desmosomal diseases of the skin, mucous membranes, and
heart. These papers are also examples of how a synergistic
approach that utilizes the tools of genetic engineering in
mice, human genetics, cell and molecular biology and
immunology have led to a signiﬁcant advancement of our
understanding of the pathological mechanisms underlying
desmosomal diseases. We sincerely thank the authors for
their high-quality and exciting contributions. We hope that
these provocative papers will stimulate discussions and
promote future collaborations.
BasicBiologicalFeatures
The paper entitled “Desmosomes in vivo” D. Garrod discusses
the importance of desmosome assembly and disassembly2 Dermatology Research and Practice
during development and in disorders such as blistering
diseases of the skin. Most of our understanding of the
underlying regulatory mechanisms has been gathered from
investigations on cultured cells where desmosomes are in a
calcium-dependent as opposed to a calcium-independent or
hyperadhesive state. This thought-provoking review from a
leader in the desmosomal ﬁeld critically discusses the state
of desmosomes in cell culture and in vivo, the properties
of calcium-independent desmosomes, and their reversion to
a calcium-dependent state during wound healing. Highly
instructive for researchers interested in disorders aﬀecting
desmosomal structure and function, this paper is a “must”
for young investigators in the ﬁeld (Editor: E. J. M¨ uller).
The paper entitled “Exploring the nature of desmosomal
cadherin associations in 3D”, by G. R. Owen and D. L.
Stokes, states that the expression of desmosomal proteins is
highly regulated in both a spatial and temporal manner, thus
establishing an intricate, dynamic network of proteins that
must provide both structural stability as well as ﬂexibility
to cells and tissues. This paper highlights the use of a
state-of-the-arttechnique known ashigh-resolution electron
tomography, to examine the interactions between cadherins
within the desmosome structure. The ﬁndings from these
studies oﬀer us an architectural perspective of cadherin
interactions and how the binding of pathogenic pemphigus
antibodies to these cadherins could disrupt desmosome
adhesionandinduceintra-epithelialblistering(Editor:M.G.
Mahoney).
“Leaving the desmosome—the desmosomal plaque proteins
of the plakophilin family” by S. Neuber et al. reviews the
diverse cell adhesion-dependent and adhesion-independent
functions of junctional proteins. In this paper, the authors
discuss the plakophilin family of proteins and the com-
plexity of their roles, which ranges from cell signaling to
organization of the cytoskeleton and control of protein
biosynthesis. Aberrant expression and disrupted function
of these proteins can result in abnormal tissue and organ
development (Editor: M. G. Mahoney).
“Desmosomesindevelopinghumanepidermis”byS.P elto-
nen et al. tackles a rare topic: the distribution of desmosomes
and other adhesive structures in the developing epidermis
of human embryos. The authors encourage investigators
in skin to complement these existing data by mechanistic
analyses that can link up with current knowledge obtained
from animal models. Of great value for the reader, this
paper provides a comprehensive insight into the time line of
epidermal morphogenesis from the surface ectoderm to the
periderm and stratiﬁed epithelium (Editor: E. J. M¨ uller).
DiseaseModels
The paper entitled “Desmosomal molecules in and out of
adhering junctions—normal and diseased states of epidermal,
cardiac and mesenchymally derived cells”b yS .P i e p e r h o ﬀ et
al. explores the heterogeneity of cell junctions in terms of
morphology and composition and how these factors relate
to the development of diseases. Special emphasis is given to
cell-cell junctions of the mammalian heart, a target organ
for severe diseases caused by impaired desmosome function
( E d i t o r :P .J .K o c h ) .
“A new prospective on intercalated disc organization—
implicationsforheartdisease”byJ.LiandG.L.Radicereviews
arrhythmogenic right ventricular cardiomyopathy/dysplasia
(ARVC/D), an inherited ﬁbrotic heart muscle disease result-
ing from mutations in many desmosomal proteins including
plakoglobin, desmoplakin, plakophilin-2, and desmoglein-
2. The skin and the heart are two tissues that undergo
tremendous mechanical stress. Unlike in the skin, where
the adherens junctions are distinct from the desmosomes,
in the heart they are integrated into a specialized hybrid
structure called the area composita, localized in the cardiac
intercalated discs. In their paper, Li and Radice discuss the
crosstalk among diﬀerent junctions and their implications in
the pathophysiology of ARVC/D (Editor: M. G. Mahoney).
The paper entitled “Desmosomal component expression in
normal, dysplastic and oral squamous cell carcinoma”b yN .
Narayana et al. shows that during malignant transformation,
cell-cell adhesion is often reorganized with dramatic changes
in various junctional proteins. The authors showed that the
desmomal plaque proteins desmoplakin and plakophilin-1
are downregulated in dyplasias and squamous cell carcino-
mas as compared to control epithelia. The results identify
these proteins as potential markers for neoplastic lesions of
the oral cavity (Editor: M. G. Mahoney).
In the paper entitled “Loss of the desmosomal component
perp impairs wound healing in vivo”b yV .G .B e a u d r ye t
al., the authors investigated cutaneous wound healing in
mice with a conditional null mutation in the desmoso-
mal Perp gene. The mice showed a delay in cutaneous
wound healing, suggesting that desmosome formation or
desmosomeremodelingmightplayanimportantroleduring
reepithelialization of skin wounds (Editor: P. J. Koch).
Wier et al.’s “Experimental human cell and tissue models
of pemphigus” discusses the advantages and disadvantages
of various in vitro skin models (keratinocyte cultures,
raft cultures, reconstructed skin, and human and mouse
keratinocyte grafts) used to study the pathophysiology of
pemphigus, a group of human autoimmune bullous diseases
( E d i t o r :P .J .K o c h ) .
“Mouse models for blistering skin disorders”b yR .G a n e -
shan et al. discusses the important roles that autoantibodies
play in autoimmune diseases such as pemphigus vulgaris,
with antibodies targeting several proteins including the
desmosomal cadherins, desmoglein-3, and desmocollin-3.
In this paper the authors explore the expression patterns
of desmoglein-3 and desmocollin-3 in various stratiﬁed
epithelial tissues including skin. Furthermore, the authors
discussgeneticallyengineeredDsg3-nullandDsc3-nullmice,
which develop blistering phenotypes similar to human
pemphigus vulgaris patients, thus providing insights into
the roles of these proteins in cell-cell adhesion and intra-
epidermal blister formation (Editor: M. G. Mahoney).
The paper entitled “Suprabasal Dsg2 expression limits
epidermal blister formation mediated by pemphigus foliaceus
antibodies and exfoliative toxins” by D. Brennan et al. demon-
strates that, upregulation of Dsg2 in the upper epidermis of
mice can compensate for a loss of Dsg1 function inducedDermatology Research and Practice 3
by pathogenic pemphigus foliaceus antibodies or exfoliative
toxins, thus preventing blistering. This supports the idea
that compensatory upregulation of desmogleins could be
a therapeutic approach to suppress skin blistering in PF
( E d i t o r :P .J .K o c h ) .
“Apoptotic pathways in pemphigus” by M. Bektas et al. is a
comprehensive review of pemphigus, a group of devastating
human autoimmune blistering diseases of the skin and
oral mucosa. Although the major uncontested culprits of
the disease are the autoantibodies to desmogleins, the
pathomechanism of pemphigus is still a heavily debated
topic. In this review, they explore the role of cellular
apoptosis in pemphigus and summarize substantial evidence
suggesting that blister formation can occur independent of
apoptosis.However,theauthorssuggestthattheactivationof
proapoptoticproteinsmayplayimportantrolesinsensitizing
the keratinocytes to the acantholytic eﬀects of pemphigus
IgG (Editor: M. G. Mahoney).
In “Targetedimmunotherapywithrituximableadstotran-
sient alteration of the IgG autoantibody proﬁle in pemphigus
vulgaris”b yR a l fM ¨ uller et al., the authors present a clinical
evaluation of the B-cell-depleting antibody rituximap in
pemphigus patients. The results support the notion that this
treatment can lead to a reduction of pathogenic antibodies
and, consequently, a temporary disappearance of disease
symptoms (Editor, P. J Koch).
In “Hypothesis concerning a potential involvement of
ceramide in apoptosis and acantholysis induced by pemphigus
autoantibodies” by W. B. Bollag, the author presents an
excitingandprovocativenewhypothesislinkingcertaintypes
of pemphigus to abnormal ceramide metabolism (Editor:
P. J. Koch).
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